Gamal, A., Chu, S., McCormick, T. S., Borroto-Esoda, K., Angulo, D., & Ghannoum, M. A. (2021). Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata. Front Cell Infect Microbiol.
استشهاد بنمط شيكاغوGamal, Ahmed, Sherman Chu, Thomas S. McCormick, Katyna Borroto-Esoda, David Angulo, و Mahmoud A. Ghannoum. "Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida Glabrata." Front Cell Infect Microbiol 2021.
MLA استشهادGamal, Ahmed, et al. "Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida Glabrata." Front Cell Infect Microbiol 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.